Tactile Systems Technology’s Flexitouch plus, used for treating lymphedema, is now commercially available in the United States after receiving 510(k) approval from the FDA.

The Flexitouch plus features system controller improvements such as the ability to create and save preset therapy programs.

The controller also features a color display and the capability of treating both legs at once for faster bilateral therapy.